Fast Track Designation
PFS in Patients with Platinum-Resistant Ovarian Cancer Is Not Improved by Batiraxcept
Source – Aravive The Phase III AXLerate-OC trial (NCT04300140) assessing the combination of batiraxcept with paclitaxel has not met its ...
IVS-3001 been given Fast Track Designation by the FDA for RCC
The FDA has granted fast track designation (FTD) to IVS-3001, an innovative chimeric antigen receptor (CAR) T-cell therapy, intended for ...
Selinexor Receives Fast Track Designation from FDA for Myelofibrosis Treatment
Source – Karyopharm Therapeutics The FDA has granted fast track designation to selinexor (Xpovio) for the treatment of patients with ...
Paxalisib With Radiation Receives Fast Track Designation from FDA for Brain Metastases
The FDA has granted fast track designation to the combination of paxalisib (GDC-0084) and radiation for the treatment of patients ...
Zenocutuzumab receives Breakthrough Designation from the FDA for NRG1+ Pancreatic Cancer
Source – Merus On July 5, The FDA has granted breakthrough therapy designation to zenocutuzumab (MCLA-128) as a treatment for ...
Quaratusugene Ozeplasmid Plasmid Plus Atezolizumab in ES-SCLC Receives FTD from FDA
Source – Genprex On June 28, 2023, Genprex has announced that the FDA has granted fast track designation (FTD) to ...
The FDA expedites the development of GSK’s vaccine for gonorrhea
Source – GSK GSK’s vaccine for gonorrhea has received a fast-track designation from the FDA, signaling its potential to combat ...
SAR’579/IPH6101 Granted FDA Fast Track Designation for Hematological Malignancies
Source: Innate Pharma On June 6, 2023, the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ...
